Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for AbbVie
Company Monitoring Page for AbbVie
latest headlines for company on cafepharma
AbbVie oncology pipeline continues to show progress
Medical Marketing and Media
Mon, 12/8/14 - 11:21 pm
Tags:
AbbVie
,
oncology
Sovaldi Versus Abbvie Combination: Analysis Of Abbvie Combination Impact On Sovaldi Market Share
Seeking Alpha
Tue, 12/2/14 - 08:54 am
Tags:
Sovaldi
,
AbbVie
,
Gilead Sciences
,
hepatitis C
AbbVie adds children's AIDS drugs to shared patent pool
Yahoo/Reuters
Mon, 12/1/14 - 07:56 am
Tags:
AbbVie
,
AIDS
,
patents
AbbVie Acquires Manufacturing Facility in Singapore; Further Expands Capabilities in Asia
Yahoo
Fri, 11/21/14 - 08:12 am
Tags:
AbbVie
,
Singapore
,
drug manufacturing
,
Asia
Europe gives green light to AbbVie hepatitis C medicine, others
Yahoo/Reuters
Fri, 11/21/14 - 08:11 am
Tags:
Europe
,
AbbVie
,
hepatitis C
,
dasabuvir
,
Sanofi
,
eliglustat
,
Novartis
,
secukinumab
,
Merck
,
Vorapaxar
,
Boehringer Ingelheim
,
nintedanib
Why are M&A hedge funds gun shy? Blame AbbVie for killing its Shire deal
Fierce Pharma
Fri, 11/14/14 - 09:53 am
Tags:
M&A
,
AbbVie
,
Shire
4 Top Pharmaceutical Companies Helping Combat Hepatitis C Near Epidemic
24/7 Wall St
Thu, 11/13/14 - 09:34 am
Tags:
hepatitis C
,
AbbVie
,
Achillion
,
Gilead Sciences
,
Merck
Are Expensive Biotech Drugs Bad For Business?
Seeking Alpha
Tue, 11/11/14 - 10:53 am
Tags:
drug pricing
,
biotech
,
AbbVie
,
AstraZeneca
,
Bristol-Myers Squibb
,
Dendreon
,
Gilead Sciences
,
GSK
,
Merck
,
Novartis
,
Teva Pharmaceutical
,
Vertex Pharmaceuticals
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tue, 11/11/14 - 09:55 am
Tags:
AbbVie
,
hepatitis C
,
ombitasvir
,
ritonavir
,
dasabuvir
,
ABT-450
Biotech stocks to watch ahead of liver disease conference
CNBC
Fri, 11/7/14 - 03:54 pm
Tags:
liver disease
,
Gilead Sciences
,
Intercept Pharma
,
Genfit
,
Merck
,
Achillion
,
AbbVie
,
NASH
,
hepatitis B
,
hepatitis C
Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
Motley Fool
Fri, 11/7/14 - 10:11 am
Tags:
AbbVie
,
Gilead Sciences
,
Enanta
,
Harvoni
,
hepatitis C
Who Needs AbbVie? Goldman Adds Shire to Conviction List
WSJ Online
Wed, 11/5/14 - 07:32 pm
Tags:
Shire
,
AbbVie
,
M&A
Investors Could Triple Their Investments in AbbVie
Yahoo/Guru Focus
Sat, 11/1/14 - 12:48 pm
Tags:
AbbVie
AbbVie CEO: Unlikely to Pursue Another $50 Billion Deal
WSJ Online
Fri, 10/31/14 - 02:02 pm
Tags:
AbbVie
,
M&A
,
Rick Gonzalez
AbbVie Raises Earnings Guidance After Humira Sales Surge
Bloomberg
Fri, 10/31/14 - 08:23 am
Tags:
AbbVie
,
earnings
,
Humira
AbbVie Expected To Post Mixed Q3 Results
Bidness Etc.
Wed, 10/29/14 - 10:16 am
Tags:
AbbVie
,
earnings
U.S. law firm says investigating AbbVie over collapsed Shire deal
Yahoo/Reuters
Wed, 10/29/14 - 10:13 am
Tags:
AbbVie
,
Shire
,
M&A
Shire’s Got Big Plans for AbbVie’s Breakup Fee
WSJ Online
Fri, 10/24/14 - 07:05 pm
Tags:
AbbVie
,
Shire
,
M&A
,
Allergan
AbbVie finally admits it was trying to dodge U.S. taxes
Fortune
Wed, 10/22/14 - 06:57 pm
Tags:
AbbVie
,
Shire
,
tax inversions
,
M&A
AbbVie's $55B deal for Shire is officially dead. Now what?
Fierce Biotech
Tue, 10/21/14 - 09:26 am
Tags:
AbbVie
,
Shire
,
M&A
Pages
« first
‹ previous
…
61
62
63
64
65
66
67
68
69
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
an umbrella protects you from: rain, sand, hunger
*
Fill in the blank.